|
KMID : 0363120240370010073
|
|
Korean Journal of Pain
2024 Volume.37 No. 1 p.73 ~ p.83
|
|
|
Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study
|
|
Oh Jin-Young
Yeo Jin-Seok
|
|
|
Abstract
|
|
|
Background: Failed back surgery syndrome (FBSS) is a chronic condition that is characterized by persistent back pain following one or more spinal surgeries. Pharmacological interventions, such as the use of opioids and gabapentinoids, are frequently used in the treatment of FBSS. However, prolonged and excessive use of these medications can lead to dependence and adverse effects. This study investigates trends in opioid and gabapentinoid prescriptions among patients with FBSS in Korea from 2016 to 2020.
Methods: Data from the Health Insurance and Review Agency were analyzed, and claims listing FBSS were selected for the study. Prescription patterns of opioids and gabapentinoids were classified based on the number of days prescribed per year.
Results: Of the 390,095 patients diagnosed with FBSS, 41.6% of the patients were prescribed gabapentinoids, and 42.0% of them were prescribed opioids, while 10.6% of the patients were classified as long-term gabapentinoid users, 11.4% as long-term opioid users, and 7.4% of the patients were found to have long-term prescriptions for both drugs. The proportion of patients who received both gabapentinoid and opioid prescriptions increased annually. The doses of opioids prescribed have also increased along with the increase in the number of patients receiving opioid prescriptions.
Conclusions: The prescription rates of opioids and gabapentinoids among patients with FBSS in Korea continue to increase steadily, posing potential risks of addiction and adverse effects. Further research is needed to better understand the actual status of addiction in patients with FBSS.
|
|
|
KEYWORD
|
|
|
Analgesics, Opioid, Big Data, Drug-Related Side Effects and Adverse Reactions, Failed Back Surgery Syndrome, Gabapentin, Insurance, Health, National Health Programs, Pregabalin, Prescriptions
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|
|